Menu
Back to Journals » OncoTargets and Therapy » Volume 14
Case report
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,827 | Dovepress* | 4,261+ | 630 | 4,891 | |
| PubMed Central* | 566 | 168 | 734 | ||
| Totals | 4,827 | 798 | 5,625 | ||
| *Since 7 May 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 1 | 1 | 2 |
View citations on PubMed Central and Google Scholar